Dexcom stock drops 40% after reporting CGM sales challenges
Dexcom stock drops 40% after reporting CGM sales challenges chale Fri, 07/26/2024 - 11:26
Fri Jul 26, 2024 19:12
BMS axes multiple myeloma bispecific months after filing to run phase 3 trial
BMS axes multiple myeloma bispecific months after filing to run phase 3 trial ntaylor Fri, 07/26/2024 - 08:09
Fri Jul 26, 2024 15:47
Chutes & Ladders—Moderna co-founder Robert Langer leaves board as David Rubenstein joins
Chutes & Ladders—Moderna co-founder Robert Langer leaves board as David Rubenstein joins gmasson Thu, 07/25/2024 - 17:44
Fri Jul 26, 2024 15:47
Acticor halts phase 2/3 stroke trial for blood thinner over futility
Acticor halts phase 2/3 stroke trial for blood thinner over futility jwaldron Fri, 07/26/2024 - 06:33
Fri Jul 26, 2024 15:18
Fierce 15: Where are they now?
Fierce 15: Where are they now? aellison Thu, 07/25/2024 - 10:03
Fri Jul 26, 2024 14:20
Calliditas' liver disease trial hits primary endpoint after sweeping changes to design
Calliditas' liver disease trial hits primary endpoint after sweeping changes to design ntaylor Fri, 07/26/2024 - 05:34
Fri Jul 26, 2024 12:51
Build your own newsfeed
Ready to give it a go?
Start a 14-day trial, no credit card required.